Saama AI Clinical Data and Agentic Solutions Platform

Saama Technologies is an AI company headquartered in Campbell, California, with offices in Pune, Chennai and Coimbatore (India), London, Solothurn, Warsaw and Kitchener. It builds an AI-driven clinical data management platform for pharmaceutical and biotech companies, aimed at the slow, manual work of cleaning, reviewing and reporting trial data. Saama states its platform powered the clinical trial behind the first COVID-19 vaccine.

The platform's Clinical Data Foundation includes Data Hub, Smart Data Quality, Smart Medical Coding, Operational Insights, Patient Insights and an Agentic Document Generator. For statistical programming and submissions, the BRAIN suite covers SDTM, a statistical computing environment and visualisation, joined by agentic tools such as SDTM Navigator and ADaM Navigator. An Agentic AI Framework deploys specialised agents across the clinical development lifecycle.

• Data Hub: unified repository for clinical trial data from many sources.
• Smart Data Quality: AI-assisted data cleaning and discrepancy detection.
• Smart Medical Coding: automated coding of adverse events and medications.
• BRAIN suite: SDTM conversion, statistical computing environment and visualisation.
• SDTM and ADaM Navigators: agentic generation of specs, programs and define.xml.
• Agentic Document Generator: GenAI support for drafting clinical documents.

Vietnamese CROs offering data management and biostatistics services can automate SDTM and ADaM production for foreign sponsors. Pharmaceutical companies running bioequivalence or phase III studies can speed up data cleaning and medical coding. Hospital research centres can use Patient Insights for faster patient data review.

Saama reports a 35% reduction in time to data discovery with Data Hub and more than 20,000 hours of manual work saved with Smart Data Quality. Patient Insights is cited at 40% time savings for patient data review, and the AI-powered document generator at 30% less content drafting time. Six functional domains are covered, with claimed reductions of up to 60% in clinical data management effort.

Sponsors and CROs are adopting agentic AI to cut data management and biostatistics effort, while CDISC standards remain mandatory for regulatory submissions. As more global trials and data management work move to Asia, CROs and biometrics teams in Vietnam and Southeast Asia need tools that automate CDISC conversion and data review.

Headquartered in Campbell, California, with offices in India (Pune, Chennai, Coimbatore), UK, Switzerland, Poland and Canada. Holds 8 patents. Named a Luminary in Everest Group's AI Applications in Clinical Development 2026; Smart ClinSAP won the 2026 CDISC AI Innovation Challenge. Launched the Astraa brand for non-life-science analytics.